PMA
GILD icon

Prudent Man Advisors’s Gilead Sciences GILD Stock Holding History

Prudent Man Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$671K Buy
5,311
+552
+12% +$72.7K 0.15% 106
2026
Q1 		$663K Buy
+4,759
New +$666K 0.2% 94
2020
Q3 		– Sell
-9,420
Closed -$725K – 165
2020
Q2 		$725K Buy
+9,420
New +$722K 0.64% 41

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Prudent Man Advisors's GILD Position: Q2 2026 in Review

Prudent Man Advisors increased its Gilead Sciences (GILD) stake by 12% in Q2 2026, buying an estimated $72.7K and bringing the position to 5,311 shares worth $671K. The position accounts for 0.15% of the portfolio, ranked #106.

Prudent Man Advisors first reported a position in GILD in Q2 2020 and has held it in 3 quarters since. The position peaked at $725K in Q2 2020. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Prudent Man Advisors held 5,311 shares of Gilead Sciences worth $671K as of Q2 2026.
  • Prudent Man Advisors bought 552 Gilead Sciences shares in Q2 2026, an estimated $72.7K.
  • Gilead Sciences made up 0.15% of Prudent Man Advisors's portfolio in Q2 2026, its #106 holding.
  • Prudent Man Advisors first reported a position in Gilead Sciences in Q2 2020 and has held it in 3 quarters since.
  • Prudent Man Advisors's Gilead Sciences position peaked at $725K in Q2 2020.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Prudent Man Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.